Introduction: Expanding the Dementia Diagnostic Toolkit As the global population ages, dementia, including Alzheimer’s disease (AD), presents a growing clinical and economic burden. Early identification and prognosis are essential, yet current biomarkers remain imperfect, often requiring costly or invasive methods. A promising direction is the use of digital biomarkers derived from motor and cognitive assessments.…